BIYKEM BOZKURT to Double-Blind Method
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Double-Blind Method.
Connection Strength
0.070
-
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27; 103(8):1044-7.
Score: 0.035
-
Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
Score: 0.018
-
Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
Score: 0.009
-
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
Score: 0.008